{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:35:34Z","timestamp":1784892934286,"version":"3.55.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This research aimed to determine the relationships between the risk factors for nosocomial multidrug-resistant Acinetobacter baumannii (MDRAB) bacteremia and associated mortality. We analyzed 144 patients treated for A. baumannii bacteremia, including 120 patients with MDRAB bacteremia, from March 2015 to March 2020, in this retrospective study. The overall bacteremia-related mortality rate was 48.6%. The mortality rates were 25.0% and 53.3% for non-MDRAB and MDRAB bacteremia, respectively. Risk factors for the development of MDRAB bacteremia were prior use of cephalosporins [odds ratio (OR): 8.62; P\u00a0&amp;lt;\u00a0.001], carbapenems (OR: 15.04; P\u00a0&amp;lt;\u00a0.001), or quinolones (OR: 5.02; P\u00a0=\u00a0.040); indwelling urinary catheters (OR: 21.38; P\u00a0&amp;lt;\u00a0.001); and respiratory tract as the source of bacteremia (OR: 75.33; P\u00a0&amp;lt;\u00a0.001). Patients with elective surgeries were inclined to develop non-MDRAB bacteremia (OR: 0.45; P\u00a0=\u00a0.029). High scores in the Acute Physiology and Chronic Health Evaluation II (OR: 1.321; P\u00a0&amp;lt;\u00a0.001) and Sequential Organ Failure Assessment (OR: 1.326; P\u00a0&amp;lt;\u00a0.001) were risk factors for mortality from MDRAB infection. In summary, higher mortality rates occur in patients with MDRAB bacteremia, and risk factors include prior use of cephalosporins, carbapenems, or quinolones. Urinary catheters and the respiratory tract as sources of the infection increase the risk of MDRAB bacteremia.<\/jats:p>","DOI":"10.1093\/lambio\/ovae006","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T01:47:50Z","timestamp":1705974470000},"source":"Crossref","is-referenced-by-count":3,"title":["Risk factors for bacteremia and mortality due to multidrug-resistant <i>Acinetobacter baumannii<\/i>: a retrospective study"],"prefix":"10.1093","volume":"77","author":[{"given":"Haibin","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Gerontology, Wuxi No.2 People\u2019s Hospital , No. 68 Zhongshan Road, Wuxi 214000, Jiangsu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Wuxi No.2 People\u2019s Hospital , No. 68 Zhongshan Road, Wuxi 214000, Jiangsu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichi","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Wuxi No.2 People\u2019s Hospital , No. 68 Zhongshan Road, Wuxi 214000, Jiangsu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Gerontology, Wuxi No.2 People\u2019s Hospital , No. 68 Zhongshan Road, Wuxi 214000, Jiangsu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Gerontology, Wuxi No.2 People\u2019s Hospital , No. 68 Zhongshan Road, Wuxi 214000, Jiangsu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Gerontology, Wuxi No.2 People\u2019s Hospital , No. 68 Zhongshan Road, Wuxi 214000, Jiangsu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"2024020116351874000_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/MCC.0000000000000534","article-title":"Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant\/extensively drug-resistant\/pandrug-resistant bacteria","volume":"24","author":"Bassetti","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"2024020116351874000_bib2","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1128\/AAC.02441-14","article-title":"Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii\u2013calcoaceticus complex","volume":"58","author":"Chopra","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2024020116351874000_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/medicina55020049","article-title":"Ventilator-associated pneumonia due to drug-resistant Acinetobacter baumannii: risk factors and mortality relation with resistance profiles, and independent predictors of in-hospital mortality","volume":"55","author":"Ciginskiene","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"2024020116351874000_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11908-009-0050-2","article-title":"Severe hospital-acquired pneumonia: a review for clinicians","volume":"11","author":"Dallas","year":"2009","journal-title":"Curr Infect Dis Rep"},{"key":"2024020116351874000_bib5","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De\u00a0Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2024020116351874000_bib6","doi-asserted-by":"crossref","first-page":"e25298","DOI":"10.1371\/journal.pone.0025298","article-title":"Seasonal and temperature-associated increases in Gram-negative bacterial bloodstream infections among hospitalized patients","volume":"6","author":"Eber","year":"2011","journal-title":"PLoS One"},{"key":"2024020116351874000_bib7","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/jac\/dkl130","article-title":"Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy","volume":"57","author":"Falagas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2024020116351874000_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jhin.2006.04.015","article-title":"Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature","volume":"64","author":"Falagas","year":"2006","journal-title":"J Hosp Infect"},{"key":"2024020116351874000_bib9","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/320183","article-title":"Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997\u20131999)","volume":"32","author":"Gales","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2024020116351874000_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"2024020116351874000_bib11","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1086\/508360","article-title":"Colonization or infection with multidrug-resistant Acinetobacter baumannii may be an independent risk factor for increased mortality","volume":"43","author":"Gkrania-Klotsas","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2024020116351874000_bib12","doi-asserted-by":"crossref","first-page":"e2943","DOI":"10.1097\/MD.0000000000002943","article-title":"Risk factors and clinical outcomes for patients with Acinetobacter baumannii bacteremia","volume":"95","author":"Gu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2024020116351874000_bib13","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.ajic.2015.11.019","article-title":"Risk factors and outcomes of hospitalized patients with blood infections caused by multidrug-resistant Acinetobacter baumannii complex in a hospital of Northern China","volume":"44","author":"Guo","year":"2016","journal-title":"Am J Infect Control"},{"key":"2024020116351874000_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhin.2009.06.007","article-title":"Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study","volume":"73","author":"Jang","year":"2009","journal-title":"J Hosp Infect"},{"key":"2024020116351874000_bib15","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.12659\/MSM.905919","article-title":"Prognostic risk factors in ventilator-associated pneumonia","volume":"24","author":"Karakuzu","year":"2018","journal-title":"Med Sci Monit"},{"key":"2024020116351874000_bib16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1469-0691.2012.03967.x","article-title":"Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia","volume":"19","author":"Kuo","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"2024020116351874000_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jcrc.2016.09.003","article-title":"Risk prediction models for mortality in patients with ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"37","author":"Larsson","year":"2017","journal-title":"J Crit Care"},{"key":"2024020116351874000_bib18","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/CCM.0000000000000125","article-title":"Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients","volume":"42","author":"Lee","year":"2014","journal-title":"Crit Care Med"},{"key":"2024020116351874000_bib19","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1128\/AAC.00984-16","article-title":"Clinical features and risk factors for development of breakthrough Gram-negative bacteremia during carbapenem therapy","volume":"60","author":"Lee","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2024020116351874000_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/517954","article-title":"Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia","volume":"28","author":"Lee","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2024020116351874000_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1473-3099(12)70239-6","article-title":"Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study","volume":"12","author":"Levy","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2024020116351874000_bib22","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jmii.2014.10.006","article-title":"Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia","volume":"49","author":"Liu","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"2024020116351874000_bib23","doi-asserted-by":"crossref","first-page":"e0130701","DOI":"10.1371\/journal.pone.0130701","article-title":"Risk and prognostic factors for multidrug-resistant Acinetobacter baumannii complex bacteremia: a retrospective study in a tertiary hospital of West China","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"2024020116351874000_bib25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/313441","article-title":"Seasonal variation of Acinetobacter infections: 1987\u20131996. Nosocomial infections surveillance system","volume":"29","author":"McDonald","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2024020116351874000_bib24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2024020116351874000_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ejim.2009.05.005","article-title":"Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia","volume":"20","author":"Metan","year":"2009","journal-title":"Eur J Intern Med"},{"key":"2024020116351874000_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/674387","article-title":"A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia","volume":"35","author":"Ng","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2024020116351874000_bib28","doi-asserted-by":"crossref","first-page":"O1028","DOI":"10.1111\/1469-0691.12716","article-title":"A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia","volume":"20","author":"Nutman","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2024020116351874000_bib29","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1093\/cid\/cir257","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"52","author":"O'Grady","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2024020116351874000_bib30","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1086\/592698","article-title":"Summer peaks in the incidences of Gram-negative bacterial infection among hospitalized patients","volume":"29","author":"Perencevich","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2024020116351874000_bib31","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/jac\/dkq191","article-title":"Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination","volume":"65","author":"Perez","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2024020116351874000_bib32","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1469-0691.2012.03954.x","article-title":"Seasonality in Gram-negative and healthcare-associated infections","volume":"18","author":"Richet","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2024020116351874000_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jinf.2019.05.017","article-title":"Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study","volume":"79","author":"Russo","year":"2019","journal-title":"J Infect"},{"key":"2024020116351874000_bib34","doi-asserted-by":"crossref","first-page":"1053968","DOI":"10.3389\/fcimb.2023.1053968","article-title":"Deciphering the virulence factors, regulation, and immune response to Acinetobacter baumannii infection","volume":"13","author":"Shadan","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"2024020116351874000_bib35","first-page":"118","article-title":"Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control study","volume":"41","author":"Shih","year":"2008","journal-title":"J Microbiol Immunol Infect"},{"key":"2024020116351874000_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0195-6701(03)00046-X","article-title":"Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin\u2013sulbactam treatment","volume":"54","author":"Smolyakov","year":"2003","journal-title":"J Hosp Infect"},{"key":"2024020116351874000_bib37","doi-asserted-by":"crossref","first-page":"1141490","DOI":"10.3389\/fcimb.2023.1141490","article-title":"Resistance mechanisms of tigecycline in Acinetobacter baumannii","volume":"13","author":"Sun","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"2024020116351874000_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/jcm9010153","article-title":"Is polymicrobial bacteremia an independent risk factor for mortality in Acinetobacter baumannii bacteremia?","volume":"9","author":"Wang","year":"2020","journal-title":"J Clin Med"},{"key":"2024020116351874000_bib39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10096-008-0473-y","article-title":"Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance","volume":"27","author":"Wareham","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024020116351874000_bib40","doi-asserted-by":"crossref","first-page":"e14937","DOI":"10.1097\/MD.0000000000014937","article-title":"Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: a retrospective study from a Chinese hospital","volume":"98","author":"Zhou","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["Letters in Applied Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/lambio\/advance-article-pdf\/doi\/10.1093\/lambio\/ovae006\/56333879\/ovae006.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/lambio\/article-pdf\/77\/2\/ovae006\/56533780\/ovae006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/lambio\/article-pdf\/77\/2\/ovae006\/56533780\/ovae006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T16:37:58Z","timestamp":1706805478000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/lambio\/article\/doi\/10.1093\/lambio\/ovae006\/7585331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/lambio\/ovae006","relation":{},"ISSN":["1472-765X"],"issn-type":[{"value":"1472-765X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2024,1,22]]},"article-number":"ovae006"}}